News
Stereotactic radiotherapy highly effective for brain mets in RCC
Stereotactic radiotherapy is highly effective for controlling brain metastases in patients with renal cell carcinoma, even in those with more than...
News
Line complications plague dose-adjusted EPOCH-R in non-Hodgkin lymphoma
The risk of line-associated complications was significantly higher with dose-adjusted EPOCH-R therapy, compared with R-CHOP, in patients with...
News
TKIs and immunotherapy hold promise for alveolar soft part sarcoma
Tyrosine kinase inhibitors and immune checkpoint inhibitors show encouraging results in the treatment of alveolar soft part sarcoma
News
Aspirin cuts risk of liver and ovarian cancer
Regular aspirin use decreased the risk of both ovarian cancer and hepatocellular carcinoma.
News
Aspirin cuts risk of ovarian and liver cancer
Regular aspirin use decreased the risk of both ovarian cancer and hepatocellular carcinoma.
News
Epacadostat plus pembrolizumab shows promise in advanced solid tumors
Investigational drug epacadostat plus pembrolizumab demonstrated promising antitumor activity and safety in patients with advanced solid tumors....
News
Plasma GAG provides prognostic info for RCC
Plasma glycosaminoglycan (GAG) measurements can provide accurate diagnostic and prognostic information that may have clinical utility in renal...
News
RT linked with better survival in DCIS
Lumpectomy plus radiotherapy is associated with a significant reduction in breast cancer mortality versus lumpectomy or mastectomy alone.
News
Tailored hemophilia prophylaxis could cut costs
Tailored frequency-escalated prophylaxis resulted in less use of recombinant factor VIII.
News
Bisphosphonate use linked with lower risk of lung cancer for never-smokers
Use of oral bisphosphonates was associated with a lower risk of developing lung cancer in postmenopausal women, but only those who were never...
News
Fruquintinib promising agent for advanced NSCLC
Median PFS was 3.8 months with fruquintinib versus 1.1 months with placebo in heavily pretreated patients with advanced NSCLC.
News
Excellent prognosis for cystic RCC evaluated with radiologic threshold of greater than 50%
There was no evidence of tumor recurrence or metastasis from cRCC for both active surveillance and following surgery when evaluated with a...
News
Spray-dried plasma inches toward clinical trials
In vitro studies show strong results for spray-dried plasma, which could have implications on the battlefield.
News
Sotatercept promising for treatment of anemia in MDS
The phase 2 trial included patients who did not respond to erythropoiesis-stimulating agents.
News
Age at RRSO affects peritoneal cancer risk in BRCA mutation carriers
The risk was predominantly observed in BRCA1 mutation carriers, and disease development generally occurred within 5 years following RRSO.